These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 24735251)
1. The low/high BCS permeability class boundary: physicochemical comparison of metoprolol and labetalol. Zur M; Gasparini M; Wolk O; Amidon GL; Dahan A Mol Pharm; 2014 May; 11(5):1707-14. PubMed ID: 24735251 [TBL] [Abstract][Full Text] [Related]
2. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation. Zur M; Hanson AS; Dahan A Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076 [TBL] [Abstract][Full Text] [Related]
4. The biopharmaceutics of successful controlled release drug product: Segmental-dependent permeability of glipizide vs. metoprolol throughout the intestinal tract. Zur M; Cohen N; Agbaria R; Dahan A Int J Pharm; 2015 Jul; 489(1-2):304-10. PubMed ID: 25957705 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the permeability of metoprolol and labetalol in rat, mouse, and Caco-2 cells: use as a reference standard for BCS classification. Incecayir T; Tsume Y; Amidon GL Mol Pharm; 2013 Mar; 10(3):958-66. PubMed ID: 23327720 [TBL] [Abstract][Full Text] [Related]
6. Regional-dependent intestinal permeability and BCS classification: elucidation of pH-related complexity in rats using pseudoephedrine. Fairstein M; Swissa R; Dahan A AAPS J; 2013 Apr; 15(2):589-97. PubMed ID: 23440549 [TBL] [Abstract][Full Text] [Related]
7. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification. Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288 [TBL] [Abstract][Full Text] [Related]
8. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs. Dahan A; Amidon GL Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230 [TBL] [Abstract][Full Text] [Related]
9. BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide. Markovic M; Zur M; Ragatsky I; Cvijić S; Dahan A Pharmaceutics; 2020 Dec; 12(12):. PubMed ID: 33276565 [TBL] [Abstract][Full Text] [Related]
10. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests. Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256 [TBL] [Abstract][Full Text] [Related]
11. Segmental-Dependent Solubility and Permeability as Key Factors Guiding Controlled Release Drug Product Development. Markovic M; Zur M; Fine-Shamir N; Haimov E; González-Álvarez I; Dahan A Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32214015 [TBL] [Abstract][Full Text] [Related]
12. Purely in silico BCS classification: science based quality standards for the world's drugs. Dahan A; Wolk O; Kim YH; Ramachandran C; Crippen GM; Takagi T; Bermejo M; Amidon GL Mol Pharm; 2013 Nov; 10(11):4378-90. PubMed ID: 24094040 [TBL] [Abstract][Full Text] [Related]
13. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim. Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464 [TBL] [Abstract][Full Text] [Related]
14. pH-Dependent solubility and permeability criteria for provisional biopharmaceutics classification (BCS and BDDCS) in early drug discovery. Varma MV; Gardner I; Steyn SJ; Nkansah P; Rotter CJ; Whitney-Pickett C; Zhang H; Di L; Cram M; Fenner KS; El-Kattan AF Mol Pharm; 2012 May; 9(5):1199-212. PubMed ID: 22489626 [TBL] [Abstract][Full Text] [Related]
15. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation. Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569 [TBL] [Abstract][Full Text] [Related]
16. Segmental-dependent membrane permeability along the intestine following oral drug administration: Evaluation of a triple single-pass intestinal perfusion (TSPIP) approach in the rat. Dahan A; West BT; Amidon GL Eur J Pharm Sci; 2009 Feb; 36(2-3):320-9. PubMed ID: 19028572 [TBL] [Abstract][Full Text] [Related]
17. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. Takagi T; Ramachandran C; Bermejo M; Yamashita S; Yu LX; Amidon GL Mol Pharm; 2006; 3(6):631-43. PubMed ID: 17140251 [TBL] [Abstract][Full Text] [Related]
18. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport. Varma MV; Sateesh K; Panchagnula R Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173 [TBL] [Abstract][Full Text] [Related]
19. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability. Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336 [TBL] [Abstract][Full Text] [Related]
20. Biopharmaceutics classification and intestinal absorption study of apigenin. Zhang J; Liu D; Huang Y; Gao Y; Qian S Int J Pharm; 2012 Oct; 436(1-2):311-7. PubMed ID: 22796171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]